Reduced renal fractional excretion of lithium in cystic fibrosis

Br J Clin Pharmacol. 1996 Feb;41(2):157-9. doi: 10.1111/j.1365-2125.1996.tb00174.x.

Abstract

We hypothesized that patients with cystic fibrosis would have abnormal lithium handling because the genetic defect in cystic fibrosis encodes an ion channel which causes a generalized electrolyte transport disorder in epithelial membranes. Eight patients with cystic fibrosis and eight age-sex matched healthy subjects ingested 600 mg lithium carbonate and had urine and serum lithium levels assessed 24 h later. Compared with healthy subjects, the patients with cystic fibrosis had higher serum lithium levels (0.071 +/- 0.038 vs 0.113 +/- 0.055 mmol l-1, P = 0.03) and had lower fractional renal excretion of lithium (27.5 +/- 14.8 vs 18.8 +/- 9.3%, P = 0.03). Caution should be used in prescribing standard doses of lithium to patients with cystic fibrosis until more definitive data are available.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cystic Fibrosis / blood
  • Cystic Fibrosis / urine*
  • Female
  • Humans
  • Kidney / physiopathology*
  • Lithium / blood
  • Lithium / urine*
  • Lithium Carbonate / administration & dosage
  • Lithium Carbonate / pharmacokinetics
  • Male

Substances

  • Lithium Carbonate
  • Lithium